Key result
First-year postgraduate physicians appropriately held non-compliant platelet orders from release less often than senior trainees.
Why the study?
Apheresis platelets carry high costs, limited supply, and risks of reactions and refractoriness in hematopoietic transplant patients, necessitating close monitoring of transfusion guideline compliance.
Does physician training level (PGY1 vs PGY>1) affect compliance with hospital transfusion policy for platelet doses?
Observational
Does physician training level (PGY1 vs PGY>1) affect compliance with hospital transfusion policy for platelet doses?
PGY1 physicians are significantly less likely to appropriately hold non-compliant platelet transfusions compared to more senior trainees, leading to substantial unnecessary costs.
Answers are grounded in this paper and cite their sources.
PGY1 trainee audits match later-year accuracy for platelet transfusion appropriateness; reinforces scalable quality assurance while leaving open effects on long-term utilization.
Apheresis platelets are a product with high cost and limited supply commonly used for hematopoietic transplant patients. There is potential for both transfusion reactions and refractoriness associated with this product. Therefore, transfusion guideline compliance is closely monitored. This is a quality assurance review of a prospective platelet audit covering an 18-month period. Audit records created by trainees in their first post graduate year (PGY1) were compared to subsequent years. Multivariate regression analysis considered the variables of patient age, sex, PGY level, and platelet count. Financial modeling was derived for best case (low cost), base case (average cost), and worst case (high cost) scenarios. There were 1931 platelet doses requiring approval with 1122 (58%) compliant with hospital transfusion policy and 809 (42%) not compliant. Products ordered but not compliant with hospital policy were appropriately held from release by PGY1 physicians for 186/428 (43%) doses and 279/381 (73%) doses by PGY > 1 physicians (P < .01). Multivariate analysis demonstrated significance only in the categories of PGY level and platelet count. The ordered doses not compliant with hospital policy had an estimated minimal cost of $404 500. There were a disproportionately higher number of platelets released by the PGY1 group. Potential mitigation strategies for this include a closer level of oversight or hiring a patient blood manager to provide real-time metrics. Prevention of unnecessary transfusions is important in hematopoietic transplant patients both to prevent infections and decrease foreign antigen exposure and transfusion refractoriness.
No takes yet. Share an insight, caveat, or question.
Vossoughi et al. (2020) conducted an observational in Hematopoietic transplant patients requiring apheresis platelets. First-year postgraduate (PGY1) physician level vs. PGY > 1 physician level was evaluated on Appropriately holding non-compliant platelet orders from release (p=< .01). First-year postgraduate physicians appropriately held non-compliant platelet orders from release less often than senior trainees.
Synapse has enriched 10 related papers. Consider them for comparative context: